Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,931 | 36,478 | 28,982 | 16,765 | 22,794 |
| Marketable Securities | 58,034 | 66,118 | 27,068 | 55,213 | 64,539 |
| Receivables | 8,897 | 9,525 | 10,441 | 11,421 | 11,761 |
| Inventories | 18,201 | 17,266 | 15,348 | 15,634 | 16,473 |
| TOTAL | $113,611 | $132,932 | $88,340 | $109,011 | $122,467 |
| Non-Current Assets | |||||
| PPE Net | 39,605 | 40,289 | 42,449 | 14,560 | 14,003 |
| Other Non-Current Assets | 4,688 | 4,684 | 4,719 | 14,313 | 14,165 |
| TOTAL | $44,293 | $44,973 | $47,168 | $28,873 | $28,168 |
| Total Assets | $157,904 | $177,905 | $135,508 | $137,884 | $150,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,574 | 6,514 | 8,221 | 8,359 | 8,311 |
| Accrued Expenses | 11,232 | 17,840 | 17,246 | 16,604 | 16,482 |
| Other current liabilities | 1,428 | 1,915 | 167 | 1,681 | 742 |
| TOTAL | $30,292 | $35,694 | $35,440 | $33,774 | $32,106 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,456 | 10,441 | 13,302 | 16,106 | 15,794 |
| Deferred Revenues | 6,151 | 6,782 | 6,683 | 7,130 | 6,571 |
| Other Non-Current Liabilities | 170 | 14,614 | 16,097 | 2,020 | 1,823 |
| TOTAL | $26,204 | $26,351 | $30,883 | $19,442 | $19,849 |
| Total Liabilities | $56,496 | $62,045 | $66,323 | $53,216 | $51,955 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,250 | 115,592 | 93,551 | 92,725 | 92,647 |
| Common Shares | 116 | 116 | 94 | 93 | 93 |
| Retained earnings | -858,971 | -836,950 | -811,411 | -787,544 | -768,514 |
| Other shareholders' equity | -2 | -16 | -3 | 5 | 23 |
| TOTAL | $101,408 | $115,860 | $69,185 | $84,668 | $98,680 |
| Total Liabilities And Equity | $157,904 | $177,905 | $135,508 | $137,884 | $150,635 |